Unaccustomed physical activity induces muscle damage which is reflected by elevated serum levels of myoglobin (Myo), creatine kinase (CK), and aspartate-aminotransferase (ASAT). An acute phase reaction, e.g. an elevation of C-reactive protein (CRP), is known to occur with heavy exercise. To influence this reaction some authors recommend non-steroidal antirheumatic drugs like Diclofenac. 16 experienced male participants of the Swiss Alpine Marathon Davos (67 km, altitude difference 2300 m, average running time 8.5 h) received Diclofenac orally (75 mg Voltaren® SR 24, 12, and 1 h pre-race), while 11 additional male subjects served as controls. Myo, CK, ASAT, and CRP were measured 1 day pre-race, at the start, at the finish, 2 h, 1 day, and 2 days after the race. A significant elevation in all parameters occurred immediately after the race (Wilcoxon ranksum test). There was no difference between treated and non-treated group (Mann-Whitney U-test). The Myo level peaked at the finish (814 μg/L; 95% CI, 759-869), whereas CK, ASAT, and CRP levels peaked 1 day after the race (6601 U/L, 4342-8860; 211 U/L, 160-262; 26 mg/L, 22-30). In the control group, the Myo value at the finish was correlated with the 1 day post-race CRP level (Spearman r=0.68, p=0.03). Further, CK and ASAT correlated significantly with the 1 day post-race CRP level at the finish, 1 and 2 days post-race (r>0.65, p<0.04). In contrast, no such correlation was found in the Diclofenac treated group. Diclofenac did not change the elevation of the analyzed parameters, but might have interfered with the regulation of muscle damage and/or the acute phase reaction.
Read full abstract